Maintenance treatment with thalidomide after autologous transplantation for myeloma:: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome".

被引：0

作者：

Attal, M ^{[1
]}

Harousseau, JL ^{[1
]}

Leyvraz, S ^{[1
]}

Doyen, C ^{[1
]}

Hulin, C ^{[1
]}

Benboubker, L ^{[1
]}

Agha, IY ^{[1
]}

Bourhis, JH ^{[1
]}

Garderet, L ^{[1
]}

Sotto, JJ ^{[1
]}

Michallet, M ^{[1
]}

Renaud, M ^{[1
]}

Voillat, L ^{[1
]}

Berthou, C ^{[1
]}

Marit, G ^{[1
]}

Monconduit, M ^{[1
]}

Dumonté, C ^{[1
]}

Caillot, D ^{[1
]}

Mathiot, C ^{[1
]}

Avet-Loiseau, H ^{[1
]}

机构：

[1] Hop Purpan, Hematol Serv, Toulouse, France

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1148

引用

页码：335A / 335A

页数：1

共 50 条

[11] Growth Differentiation Factor 15 Plasma Level in patients with Multiple Myeloma: A Study of Intergroupe Francophone Du Myelome.
Corre, Jill
Roussel, Murielle
Huynh, Anne
Gadelorge, Melanie
Labat, Elodie
Laharrague, Patrick
Moreau, Philippe
Facon, Thierry
Avet-Loiseau, Herve
Fournie, Jean-Jacques
Attal, Michel
Bourin, Philippe
BLOOD, 2008, 112 (11) : 934 - 934
[12] Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination before and after Autologous Stem Cell Transplantation (ASCT) Followed By Ixazomib Maintenance in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du MyeLome (IFM)
Moreau, Philippe
Hulin, Cyrille
Caillot, Denis
Marit, Gerald
Perrot, Aurore
Garderet, Laurent
Facon, Thierry
Benboubker, Lotfi
Karlin, Lionel
Tiab, Mourad
Arnulf, Bertrand
Fermand, Jean-Paul
Leleu, Xavier
Touzeau, Cyrille
Roussel, Murielle
Planche, Lucie
Minvielle, Stephane
Bene, Marie-Christine
Avet-Loiseau, Herve
Dejoie, Thomas
Attal, Michel
BLOOD, 2016, 128 (22)
[13] Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Royer, Bruno
Banos, Anne
Benramdane, Riad
Cony-Makhoul, Pascale
Dib, Mamoun
Fontan, Jean
Stoppa, Anne-Marie
Traulle, Catherine
Vilque, Jean-Pierre
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
Moreau, Philippe
BLOOD, 2013, 122 (21)
[14] Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myelome
Roussel, Murielle
Lauwers-Cances, Valerie
Robillard, Nelly
Hulin, Cyrille
Leleu, Xavier
Benboubker, Lotfi
Marit, Gerald
Moreau, Philippe
Pegourie, Brigitte
Caillot, Denis
Fruchart, Christophe
Stoppa, Anne-Marie
Gentil, Catherine
Wuilleme, Soraya
Huynh, Anne
Hebraud, Benjamin
Corre, Jill
Chretien, Marie-Lorraine
Facon, Thierry
Avet-Loiseau, Herve
Attal, Michel
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2712 - +
[15] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma
Grosskreutz, CL
Egan, R
Scigliano, E
Fruchtman, SM
Isola, LM
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 73 - 73
[16] Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)
Roussel, Murielle
Moreau, Philippe
Huynh, Anne
Mary, Jean-Yves
Danho, Clotaire
Caillot, Denis
Hulin, Cyrille
Fruchart, Christophe
Marit, Gerald
Pegourie, Brigitte
Lenain, Pascal
Araujo, Carla
Kolb, Brigitte
Randriamalala, Edouard
Royer, Bruno
Stoppa, Anne-Marie
Dib, Mammoun
Dorvaux, Veronique
Garderet, Laurent
Mathiot, Claire
Avet-Loiseau, Herve
Harousseau, Jean-Luc
Attal, Michel
BLOOD, 2010, 115 (01) : 32 - 37
[17] Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myelome
Royer, Bruno
Minvielle, Stephane
Diouf, Momar
Roussel, Murielle
Karlin, Lionel
Hulin, Cyrille
Arnulf, Bertrand
Macro, Margaret
Cailleres, Sylvie
Brion, Annie
Brechignac, Sabine
Belhadj, Karim
Chretien, Marie Lorraine
Wetterwald, Marc
Chaleteix, Carine
Tiab, Mourad
Leleu, Xavier
Frenzel, Laurent
Garderet, Laurent
Choquet, Sylvain
Fuzibet, Jean Gabriel
Dauriac, Charles
Fornecker, Luc-Matthieu
Benboubker, Lotfi
Facon, Thierry
Moreau, Philippe
Avet-Loiseau, Herve
Marolleau, Jean Pierre
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18) : 2125 - +
[18] Bone marrow versus blood as source of hematopoietic stem cells after high dose therapy in multiple myeloma: A prospective, randomized study of the ''Intergroupe Francais du Myelome'' (IFM)
Harousseau, JL
Attal, M
Payen, C
Facon, T
Michaux, JL
Guilhot, F
Moconduit, M
Fuzibet, JG
Caillot, D
Dorvaux, V
Cahn, JY
Grobois, B
Stoppa, AM
Ifrah, N
Sotto, JJ
Pignon, B
Bataille, R
BLOOD, 1997, 90 (10) : 1018 - 1018
[19] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma.
Grosskreutz, CL
Egan, R
Scigliano, E
Fruchtman, SM
Isola, LM
BLOOD, 2003, 102 (11) : 489B - 490B
[20] Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination before and after Autologous Stem Cell Transplantation ( ASCT) Followed By Ixazomib Maintenance Is a Safe and Effective Strategy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du MyeLome (IFM)
Moreau, Philippe
Hulin, Cyrille
Caillot, Denis
Marit, Gerald
Perrot, Aurore
Garderet, Laurent
Facon, Thierry
Benboubker, Lofti
Karlin, Lionel
Tiab, Mourad
Arnulf, Bertrand
Leleu, Xavier
Touzeau, Cyrille
Roussel, Murielle
Planche, Lucie
Avet-Loiseau, Herve
Dejoie, Thomas
Attal, Michel
BLOOD, 2017, 130

← 1 2 3 4 5 →